| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥27.93 |
| 52 Week High | CN¥30.49 |
| 52 Week Low | CN¥22.58 |
| Beta | 0 |
| 1 Month Change | 8.26% |
| 3 Month Change | 13.26% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -3.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| 605016 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 7.4% | 2.1% | 3.1% |
| 1Y | n/a | -18.5% | -13.1% |
Return vs Industry: Insufficient data to determine how 605016 performed against the CN Food industry.
Return vs Market: Insufficient data to determine how 605016 performed against the CN Market.
Price Volatility
| 605016 volatility | |
|---|---|
| 605016 Average Weekly Movement | 6.2% |
| Food Industry Average Movement | 6.8% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 605016 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 605016's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 659 | Hongjian Zhuo | www.sdblcy.com |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Fundamentals Summary
| 605016 fundamental statistics | |
|---|---|
| Market cap | CN¥6.94b |
| Earnings (TTM) | CN¥202.09m |
| Revenue (TTM) | CN¥925.89m |
34.3x
P/E Ratio7.5x
P/S RatioIs 605016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605016 income statement (TTM) | |
|---|---|
| Revenue | CN¥925.89m |
| Cost of Revenue | CN¥625.34m |
| Gross Profit | CN¥300.55m |
| Other Expenses | CN¥98.46m |
| Earnings | CN¥202.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 32.46% |
| Net Profit Margin | 21.83% |
| Debt/Equity Ratio | 3.9% |
How did 605016 perform over the long term?
See historical performance and comparison